| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af062d550914425a68e85e083f778e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3544ed8cfb7a5b6215f39db0a293653 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_839d9d652652d2fbd0d8ba5b0d249881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5145312f06b11500e6aabce2544dc3 |
| publicationDate |
2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007143156-A1 |
| titleOfInvention |
Phenylphrine pulsed release formulations and pharmaceutical compositions |
| abstract |
The invention discloses a pulsed-release formulation or a pharmaceutical composition comprising phenylephrine. The pharmaceutical composition comprises an immediate-release component and an enteric-coated component formulated together either in solid form or in a suspension. The enteric-coated component comprises microcrystals seeded with phenylephrine as an active ingredient and coated with a pH sensitive coating to delay release of the phenylephrine. The pharmaceutical composition can further comprise at least one active selected from the group consisting of an antihistamine, an analgesic, anti-pyretic, non-steroidal anti-inflammatory and mixtures of two or more said actives. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010089767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016044704-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010094996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10278930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940796-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9795571-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015317469-B2 |
| priorityDate |
2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |